The observed upregulation of TIM-3 in PIK3CA-mutated tumors may indicate a functional interaction between the PI3K signaling pathway and TIM-3–driven immunosuppression, which could have significant implications for the development of TIM-3-targeted therapies in CRC. Here, PIK3CA is linked to colorectal carcinoma.